Biora Therapeutics (FRA:4ZU) Interest Expense : €-6.70 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biora Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biora Therapeutics's interest expense for the three months ended in Sep. 2024 was € -1.82 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-6.70 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biora Therapeutics's Operating Income for the three months ended in Sep. 2024 was € -14.62 Mil. Biora Therapeutics's Interest Expense for the three months ended in Sep. 2024 was € -1.82 Mil. Biora Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biora Therapeutics Interest Expense Historical Data

The historical data trend for Biora Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biora Therapeutics Interest Expense Chart

Biora Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-7.76

-28.67

-11.18

-10.38

-9.00

Biora Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-2.43	-1.69	-2.54	-0.66	-1.82

Biora Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.70 Mil.

Biora Therapeutics (FRA:4ZU) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biora Therapeutics's Interest Expense for the three months ended in Sep. 2024 was €-1.82 Mil. Its Operating Income for the three months ended in Sep. 2024 was €-14.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €0.30 Mil.

Biora Therapeutics's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Biora Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Biora Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (FRA:4ZU) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4330 La Jolla Village Drive, Suite 300, San Diego, CA, USA, 92122

Website

https://www.bioratherapeutics.com

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Headlines

No Headlines